Researchers investigated the anticancer effects of drugs targeting human tumor-associated macrophages (TAMs) in vivo. In humanized murine models, they tested the effectiveness of an antibody to human signal regulatory protein alpha (SIRPα) for cancer immunotherapy.
GE Healthcare subsidiary expands radiation therapy partnership with Elekta
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: GE Healthcare subsidiary MIM Software